Corrigendum to Extrauterine Growth Restriction: What Is the Evidence for Better Nutritional Practices in the Neonatal Intensive Care Unit? [Newborn and Infant Nursing Reviews 14 (2014) 92-98]

摘要

In "Extrauterine Growth Restriction: What Is the Evidence for Better Nutritional Practices in the Neonatal Intensive Care Unit" published in September 2014 it was erroneously reported that"... Rochow et al. designed and completed a double blind RCT to determine if an increased incidence of metabolic acidosis was associated with the use of a new commercially available liquid human milk fortifier and whether modification of the liquid human milk fortifier (Enfamil? Acidified Liquid Human Milk Fortifier) would decrease the incidence of metabolic acidosis. The double blind RCT utilized a powdered human milk fortifier with hydrolyzed whey protein (FMS) that is made by Milupa, a European based nutrition company. Seven out of 8 infants who received the commercially available liquid human milk fortifier developed metabolic acidosis in comparison to 1 out of 7 infants who received the standard human milk fortifier. This finding resulted in the study being interrupted and the liquid human milk fortifier being modified. Metabolic acidosis continued to occur after modification and the authors noted in the overall analysis that the infants with metabolic acidosis had lower mean weight gain and a lower bone mineral content at discharge.